Clover Health Investments, Corp. reported a net income of $28 million for the second quarter, a $39 million year-over-year improvement, alongside a 56% jump in total revenues to $743 million. This notable performance, combined with increased guidance for 2026, reflects strengthened confidence in the company's growth amid rising Medicare Advantage memberships.
Key Highlights
- Net income of $28 million for Q2 2026, a $39 million turnaround from the same period last year.
- Total revenue reached $743 million, up 56% year‑over‑year, with Medicare Advantage membership rising 48% to 157,309 members.
- Adjusted EBITDA rose to $41 million, a 139% increase versus Q2 2025, while EPS of $0.07 beat the $0.03 consensus estimate.
Clover Health Investments, Corp. has announced a net income of $28 million for the second quarter, a remarkable turnaround of $39 million compared to the same period last year. This financial performance resulted in total revenues of $743 million, representing a strong 56% increase year-over-year. The company's earnings per share (EPS) of $0.07 surpassed the consensus estimate of $0.03, driving investor optimism.
Clover's shares have risen 71.8% year-to-date, reflecting significant investor confidence in the healthcare provider's business model.
Significant Financial Growth
Clover Health’s total revenue for the second quarter of 2026 reached $743 million, up from $477.6 million, indicating a year-over-year growth of 55.6%. This increase is driven primarily by an impressive 48% rise in Medicare Advantage membership, which stands at 157,309 members. The consolidated gross profit of $153 million also shows a strong performance, improving by 53.6% from the previous year.
The rise in membership directly contributes to revenue generation, suggesting effective outreach and service delivery strategies by Clover Health. Such strong growth metrics are essential as they underline the company's ability to capture a significant share of the increasingly competitive Medicare segment.
Adjusted EBITDA Soars
Clover Health reported an adjusted EBITDA of $41 million for the quarter, marking a significant increase of 139% compared to the same period in 2025. This jump underscores the group's operational efficiency and profitability, as overall expenses grew at a slower rate than revenues. The adjusted salaries and general administrative expenses, while increasing to $112.1 million, saw a reduction in percentage terms relative to total revenue, indicating improved operational leverage.
As the company continues to enhance its technology-driven care model, operational improvements are likely to further bolster profit margins in the upcoming quarters, raising expectations for sustained profitability.
Strategic Outlook and Confidence
The release of financial results accompanies an upward revision of Clover Health’s guidance for the entire fiscal year 2026. Alongside an expected average Medicare Advantage membership between 156,000 and 158,000, this revised outlook is a strong indicator of management’s confidence in sustained growth and profitability. The introduction of Clover Assistant's AI-powered platform is expected to significantly enhance patient care and operational efficiency.
Investors should consider the potential implications of this upgraded outlook amid the competitive environment of Medicare health plans.
Upcoming Conference Call
Clover Health plans to host a conference call on August 11 to discuss its recent earnings and strategic direction further. Investors will be keen to hear additional insights from company management regarding membership growth strategies and technology implementation. Such discussions will likely impact market sentiment and could provide key indicators of future performance in the evolving healthcare sector.
Peers Moving on This News
- Centene Corp (CNC) up 0.8%
- Molina Healthcare Inc (MOH) up 0.6%
- Healthequity Inc (HQY) down 0.8%
Analysis based on the Form 8-K filed 5 August 2026; figures verified against the filing and live market data.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.


_11_19_2026_08_23_11_186799.jpg)



Please wait processing your request...